Literature DB >> 23261454

TLR2 stimulates ABCA1 expression via PKC-η and PLD2 pathway.

Dae-Weon Park1, Hyung-Kyoung Lee, Ji Hyo Lyu, Haemin Chin, Sang Wook Kang, Young-Jo Kim, Yoe-Sik Bae, Suk-Hwan Baek.   

Abstract

ATP-binding cassette transporter A1 (ABCA1) is a membrane-bound protein that regulates cardiovascular disease including atherosclerosis by the efflux of excess cholesterol from cells and by suppression of inflammation. Using a mouse macrophage cell line Raw264.7, we studied the importance of toll-like receptor 2 (TLR2) on ABCA1 expression and the signaling pathway responsible for TLR2-mediated ABCA1 expression. Interestingly, our data demonstrated that treatment of macrophages with TLR2 agonist Pam(3)CSK(4) significantly increased ABCA1 mRNA and protein levels. We found that ABCA1 induction is myeloid differentiation primary response gene 88 (MyD88)-dependent as well as TLR2-dependent. ABCA1 induction upon Pam(3)CSK(4) is controlled by protein kinase C-η (PKC-η) and phospholipase D2 (PLD2). Furthermore, direct treatment of dioctanoyl phosphatidic acid (diC(8)PA) into cells also induced ABCA1 mRNA and protein indicating that PLD2-mediated PA involve in the TLR2-stimulated ABCA1 expression. Cumulatively, these results demonstrate for the first time that activation of PKC-η and PLD2 signaling pathway is an important mechanism for regulation of TLR2-induced ABCA1 expression.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23261454     DOI: 10.1016/j.bbrc.2012.11.135

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Macrophage-activating lipopeptide-2 downregulates the expression of ATP-binding cassette transporter A1 by activating the TLR2/NF-кB/ZNF202 pathway in THP-1 macrophages.

Authors:  Liangjie Peng; Zizhen Zhang; Min Zhang; Xiaohua Yu; Feng Yao; Yulin Tan; Dan Liu; Duo Gong; Huang Chong; Xiaoyan Liu; Xilong Zheng; Guoping Tian; Chaoke Tang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-02-27       Impact factor: 3.848

2.  miR-146a-5p Antagonized AGEs- and P.g-LPS-Induced ABCA1 and ABCG1 Dysregulation in Macrophages via IRAK-1 Downregulation.

Authors:  Xia Li; Zheng Ji; Si Li; Ya-Nan Sun; Jia Liu; Ying Liu; Wei Tian; Yun-Tao Zhou; Xiao-Ming Shang
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

3.  D-series Resolvins activate Phospholipase D in phagocytes during inflammation and resolution.

Authors:  Ramya Ganesan; Karen M Henkels; Krushangi Shah; Xavier De La Rosa; Stephania Libreros; Nagarjuna R Cheemarla; Charles N Serhan; Julian Gomez-Cambronero
Journal:  FASEB J       Date:  2020-10-12       Impact factor: 5.191

Review 4.  Current siRNA targets in atherosclerosis and aortic aneurysm.

Authors:  Leena Pradhan-Nabzdyk; Chenyu Huang; Frank W LoGerfo; Christoph S Nabzdyk
Journal:  Discov Med       Date:  2014-05       Impact factor: 2.970

5.  Rapid degradation of ABCA1 protein following cAMP withdrawal and treatment with PKA inhibitor suggests ABCA1 is a short-lived protein primarily regulated at the transcriptional level.

Authors:  Neelam Srivastava; Angelo B Cefalu; Maurizio Averna; Rai Ajit K Srivastava
Journal:  J Diabetes Metab Disord       Date:  2020-03-19

Review 6.  Equivocal, explicit and emergent actions of PKC isoforms in cancer.

Authors:  Peter J Parker; Sophie J Brown; Veronique Calleja; Probir Chakravarty; Mathias Cobbaut; Mark Linch; Jacqueline J T Marshall; Silvia Martini; Neil Q McDonald; Tanya Soliman; Lisa Watson
Journal:  Nat Rev Cancer       Date:  2020-11-11       Impact factor: 60.716

7.  Genetic association between 1425G/A SNP in PRKCH and hypertrophic cardiomyopathy in a Chinese population.

Authors:  Feng Ji; Qun Liu; Zeyu Feng; Xinwei Han; Zhitong Li
Journal:  Oncotarget       Date:  2017-10-31

8.  Ischemic postconditioning attenuates the inflammatory response in ischemia/reperfusion myocardium by upregulating miR‑499 and inhibiting TLR2 activation.

Authors:  Xin-Yue Zhang; Zheng Huang; Qing-Jie Li; Guo-Qiang Zhong; Jian-Jun Meng; Dong-Xiao Wang; Rong-Hui Tu
Journal:  Mol Med Rep       Date:  2020-04-30       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.